Tectonic Therapeutic | AVRO - Current Liabilities



Tectonic Therapeutic reported $11.36M in Current Liabilities for its fiscal quarter ending in June of 2025.


Current Liabilities Change Date
Adcock Ingram Holdings ZAR 2.81B 279.84M Dec/2024
Alnylam Pharmaceuticals USD 1.3B 225.22M Jun/2025
Celltrion KRW 3.4T 216.25B Mar/2025
Cspc Pharmaceutical CNY 9.63B 801.28M Dec/2024
Dianthus Therapeutics USD 20.09M 1.64M Jun/2025
Divis Laboratories Ltd 14.52B 1.61B Mar/2025
Gilead Sciences USD 11.19B 1.15B Jun/2025
Ionis Pharmaceuticals USD 897.24M 646.94M Jun/2025
Kangmei Pharma CNY 5.75B 64.58M Jun/2025
Knight Therapeutics CAD 118.15M 12.32M Sep/2024
Laboratorios Farma EUR 186.51M 29.86M Jun/2025
MacroGenics USD 39M 16.53M Jun/2025
Malin Corporation EUR 1000K 500K Dec/2024
Medical Developments International AUD 6.37M 3.17M Dec/2024
Neuren Pharmaceuticals AUD 45.76M 36.79M Dec/2024
Organigram Holdings CAD 107.28M 38.32M Jun/2025
Pfizer USD 37.73B 1.27B Jun/2025
Pharma Mar EUR 87.78M 8.29M Jun/2025
Qiagen NV USD 1.13B 611.37M Jun/2025
Roche Holding CHF 27.02B 424M Dec/2024
Sanofi 29.06B 3.16B Jun/2025
Sarepta Therapeutics USD 919.95M 314.36M Jun/2025
Sartorius EUR 1.55B 72.7M Jun/2025
Sino Biopharmaceutical CNY 19.56B 2.39B Dec/2024
Takeda JPY 2.17T 336.94B Jun/2025
Tilray USD 278.52M 15.02M Nov/2024
Zz Pientze Pharmaceu 3.2B 878.89M Jun/2025